Skip To Main Content
Arthur Allen on Muck Rack

Arthur Allen

As seen in: MSN, Wiley Online Library, Yahoo Canada, Yahoo News Malaysia, Yahoo Singapore, ABC News, Aol, Scientific American, Chicago Sun-Times, Yahoo Sports Canada and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Arthur

Contact Arthur, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

How much of a cancer drug do patients need? U. of C. doctor, others challenge the FDA, drugmakers on dosing.

|
By Arthur Allen
| Chicago Sun-Times Verified
Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him very ill. For six months in 2022, Manski received monthly infusions of nivolumab to fight advanced melanoma. The drug ruined his thyroid gland, he said, requiring him to go on a special medication for the rest of his life, and caused severe dryness in his eyes, lips and mouth.
Open in Who Shared View Duplicates (11) Issue with article?

Cancer Drugs: Are FDA-Approved Doses Too High?

|
By Arthur Allen, Christina Gursslin
| The Defender Verified
By Arthur Allen Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him very ill. For six months in 2022, Manski received monthly infusions of nivolumab to fight advanced melanoma.
Open in Who Shared Issue with article?

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

|
By Arthur Allen
| MSN Verified
; ; ; Continue reading More for You ; ; ; Continue reading More for You
Open in Who Shared View Duplicates (671) Issue with article?
See all 41 licensed articles (45 Total)